Aveanna Healthcare Holdings Inc. (AVAH)
NASDAQ: AVAHHealth CareMedical/Nursing ServicesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
AVAH stock chart
Technical analysisKey statistics
All statistics- Market cap
- $2.40B
- P/E (TTM)
- 7.86
- Forward P/E
- 12.09
- EPS (TTM)
- $1.40
- Dividend yield
- None
- 52-week range
- 5.93 – 14.71
- Day range
- 10.65 – 11.03
- Volume / Avg
- 2.17M / 2.77M
- Beta
- —
- Shares outstanding
- 218.41M
52-week range
AVAH stock today
Aveanna Healthcare (AVAH) closed at $11.01 on Nov 20, up 2.90% (+$0.31), versus the S&P 500's 3.70% decline. At this level, AVAH sits in the middle of its 52-week range of $5.93 to $14.71: 25.2% below the high, set on Sep 16, 2026 and 85.7% above the low. AVAH is up 34.8% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 26.0%.
At 7.9x trailing earnings, Aveanna Healthcare trades below the peer-group median of 65.3x. Its forward P/E of 12.1x is higher than the trailing multiple, which means analysts expect earnings to decline over the next year.
Summary generated from market data by MetaCap's automated system. Methodology
About Aveanna Healthcare
Company profileAveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS).
- Sector
- Health Care
- Industry
- Medical/Nursing Services
- CEO
- Mr. Jeffrey S. Shaner
- Headquarters
- Atlanta, GA
- Employees
- 3,500
- IPO year
- 2021
- Website
- aveanna.com
Financial highlights
Full financialsIn fiscal 2026, Aveanna Healthcare generated $2.43 billion in revenue, up 20.2% from fiscal 2024, its 6th consecutive year of revenue growth. Net income was $225.0 million, for a net margin of 9.2% versus a median of -7.0% in the prior 5 years. Gross margin was 33.3% (up from 31.4%) and operating margin 10.5%.
| Fiscal year | FY 2026 | FY 2024 | FY 2023 | FY 2022 | FY 2022 |
|---|---|---|---|---|---|
| Revenue | $2.43B | $2.02B | $1.90B | $1.79B | $1.68B |
| Growth | +20.19% | +6.82% | +6.02% | +6.50% | +12.27% |
| Net income | $225.03M | $-10.93M | $-134.52M | $-662.03M | $-117.04M |
| EPS (diluted) | $1.05 | $-0.06 | $-0.71 | $-3.57 | $-0.69 |
Analyst forecast
ForecastConsensus (11 analysts)
buy
Avg. price target
$15.20+38.06%
- Strong buy 2
- Buy 6
- Hold 3
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 12, 2026
- EPS actual vs est.
- $0.22 vs $0.19
- Surprise
- +15.79%
AVAH news
All AVAH news- Aveanna Healthcare Holdings Announces Third Quarter Financial Results and Revised 2026 GuidanceNasdaq
- Aveanna Healthcare (AVAH) Q3 2026 Earnings Call TranscriptNasdaq
- Aveanna Healthcare (AVAH) Q3 Earnings and Revenues Beat EstimatesNasdaqAVAH, A
- Aveanna Healthcare Holdings Non-GAAP EPS of $0.23 beats by $0.02, revenue of $695.5M beats by $14.88MSeeking Alpha
- Aveanna Healthcare Holdings Announces Third Quarter Financial Results and Revised 2026 GuidanceGlobeNewswire
- Aveanna Healthcare Holdings Q3 2026 Earnings PreviewSeeking Alpha
- Quant snapshot: Aveanna Healthcare and Fossil lead top-rated names, as KBC Group and DeFi Development lagSeeking Alpha
- Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to WatchNasdaqADUS, HIMS, BKD, AVAH
Aveanna Healthcare peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ADUSAddus HomeCare Corporation | 122.50 | +1.18% | $2.28B | vs AVAH |
| PRVAPrivia Health Group Inc. | 25.05 | +1.46% | $3.20B | vs AVAH |
| USPHU.S. Physical Therapy Inc. | 95.93 | +1.71% | $1.43B | vs AVAH |
| HIMSHims & Hers Health Inc. Class A | 14.60 | -8.86% | $3.42B | vs AVAH |
| WGSGeneDx Holdings Corp. Class A | 45.46 | -7.68% | $1.36B | vs AVAH |
| TDOCTeladoc Health Inc. | 7.45 | -4.36% | $1.36B | vs AVAH |
| INNVInnovAge Holding Corp. | 9.16 | +2.81% | $1.25B | vs AVAH |
| PNTGThe Pennant Group Inc. | 34.64 | +1.61% | $1.22B | vs AVAH |
Indexes, lists and sector
Aveanna Healthcare stock FAQ
What is Aveanna Healthcare's stock price today?
AVAH last traded at $11.01 as of Nov 20, 4:00 PM EST, up 2.90% on the day. Prices are delayed at least 15 minutes.
What is AVAH's P/E ratio?
AVAH trades at a trailing P/E ratio of 7.86 and a forward P/E of 12.09, compared with a median of 65.3 for its closest peers.
Who is Aveanna Healthcare's CEO?
Mr. Jeffrey S. Shaner is the chief executive officer of Aveanna Healthcare Holdings Inc., which has about 3,500 employees.
What is the AVAH 52-week high?
The 52-week high for AVAH is $14.71 and the 52-week low is $5.93. The stock is currently 25.2% below its high.